\"Investment that drives transformation\"
Labat Africa
15
Jun
Letter to Investors
Category: Labat Africa, Labat Healthcare
Dear Investor My name is Brian van Rooyen, CEO of JSE listed company Labat Africa (Labat). Listed in 1994, the Company which boasts a Level 2 B-BBEE status has operations in log...
08
May
Covid-19 Impact And Placing Of Force Fuel Proprietary Limited (“Force Fuel”) Into Business Rescue And Cautionary Announcement
Category: Labat Africa, Labat Healthcare
Shareholders are referred to the announcement released on 24 April 2020 wherein shareholders were advised that the Board of the Company were considering various options in relat...
24
Apr
Trading Statement For The Six Months Ended 29 February 2020, Impact Of Covid-19 On Recent Results And Withdrawal Of 5 Year Profit Projections
Category: Labat Africa
In terms of paragraph 3.4(b)(i) of the Listings Requirements of the Johannesburg Stock Exchange, listed companies are required to publish a trading statement as soon as they bec...
15
Apr
Labat Africa Acquires 70% Stake In Science And Technology Group – Biodata
Category: Labat Africa
JSE listed healthcare group, Labat Africa which announced in September 2019 that it was entering the CANNABIS market has announced the acquisition of a 70% interest in leading s...
14
Apr
Voluntary Announcement Relating To The Acquisition Of A 70% Interest In Leading Science, Technology And Research Group Biodata Proprietary Limited
Category: Labat Africa
Acquisition of 70% of BioData (“Acquisition”) Shareholders are advised that Labat Africa has, in conjunction with its re-positioning strategy, entered into an agreement with Dr ...
14
Apr
Director Appointment And Change in Role
Category: Labat Africa, Labat Healthcare
DIRECTOR APPOINTMENT The Board of Labat Africa (“Board”) is pleased to announce the appointment of Mr Mike Stringer (“Mike”) as an executive director on to the Board of Director...
